VRCA VERRICA PHARMACEUTICALS INC
FollowCOM SHS (common), issuer CIK 1660334
5 managers (5 13F filers) reported a position in VRCA shares at 2025-06-30, 194,019 shares in all. 4 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 5
- 13F filers
- 5
- New
- 4
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 194,019
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| MARSHALL WACE, LLPin group MARSHALL WACE, LLP | 123,953 | $65.7K | <0.01% | new | 13F-HRTimelineGroup |
| BECK MACK & OLIVER LLC | 70,000 | $37.1K | <0.01% | new | 13F-HRTimeline |
| EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L… | 49 | $26 | <0.01% | new | 13F-HRTimelineGroup |
| Essential Partners LLC | 15 | $8 | <0.01% | 13F-HRTimeline | |
| SBI Securities Co., Ltd. | 2 | $1 | <0.01% | new | 13F-HRTimeline |